Nursing Management Strategies for a Patient With an Aeson CARMAT® Total Artificial Heart: a Case Report

Introduction. Total artificial heart (TAH) devices are a viable bridge to transplantation in patients with end-stage biventricular heart failure. Among these, the Aeson CARMAT® TAH offers pulsatile flow and biocompatible materials to enhance physiological compatibility and reduce thromboembolic risks. Case Presentation. We describe the case of a 62-year-old male with ischemic cardiomyopathy and NYHA Class IV symptoms, deemed ineligible for immediate heart transplant. The patient underwent Aeson TAH implantation following multidisciplinary evaluation and was admitted to the cardiac surgery intensive care for postoperative management. Clinical Findings. Postoperative care focused on six core areas: (1) hemodynamic monitoring, including continuous tracking of pressures and device-derived values; (2) anticoagulation and bleeding control with INR-based dosing; (3) infection prevention via strict asepsis and respiratory therapy; (4) device monitoring, including waveform interpretation and alarm management; (5) patient and caregiver education on device handling and complication signs; and (6) early mobilization to prevent ICU-related complications and support functional recovery. Discussion. The case highlights the nurse’s central role in managing TAH patients, integrating technical competence with holistic support. Early identification of complications and structured education contributed to a successful recovery and preparation for transplant listing.